DAVID JOHN GRAINGER - BABRAHAM - PARTNER AT MEDICXI VENTURES (UK) LLP

DAVID JOHN GRAINGER - BABRAHAM - PARTNER AT MEDICXI VENTURES (UK) LLP

.

Overview

DR DAVID JOHN GRAINGER is a Partner At Medicxi Ventures (Uk) Llp from Babraham Cambridgeshire. This person was born in October 1966, which was over 57 years ago. DR DAVID JOHN GRAINGER is British and resident in England. This company officer is, or was, associated with at least 25 company roles.
Their most recent appointment, in our records, was to CRITICAL PRESSURE LIMITED on 2017-10-02, from which they resigned on 2021-11-24.

Address

Babraham Research Campus, C/O The Cambridge Partnership Limited
Babraham
Cambridgeshire
CB22 3AT
England

Map

Company Appointments - Current and Previous

CompanyName Company Status Role Appointed Appointment Status Assets
CRITICAL PRESSURE LIMITED Active Director 2017-10-02 until 2021-11-24 RESIGNED £246,520 cash, £331,277 equity
DC EUROPA LIMITED Liquidation Director 2017-06-20 CURRENT £397,011 cash, £273,680 equity
THE FOUNDRY (CAMBRIDGE) LIMITED Active Director 2017-06-16 CURRENT £34,696 cash, £928,281 equity
RXBIOLOGICS LIMITED Active Director 2017-03-01 CURRENT £247,924 equity
REBALANCE (CAMBRIDGE) LIMITED Dissolved - no longer trading Director 2016-12-06 CURRENT £395,914 cash, £533,987 equity
CORRECTA4 BIO LIMITED Dissolved - no longer trading Director 2016-04-19 CURRENT £190,070 cash, £183,890 equity
MEDICXI VENTURES (UK) LLP Active Llp Member 2016-01-25 until 2017-12-31 RESIGNED
ULTRAHUMAN LIMITED Active Director 2015-11-24 until 2016-01-19 RESIGNED £16,688 cash, £19,343 equity
SUPERX LIMITED Dissolved - no longer trading Director 2015-11-10 until 2016-01-07 RESIGNED £527,235 cash, £778,171 equity
HUMAN ANTIBODY FACTORY LIMITED Dissolved - no longer trading Director 2015-10-06 CURRENT £826,970 cash, £809,702 equity
ABC MEDICINES LIMITED Dissolved - no longer trading Director 2015-09-15 CURRENT £25,077 equity
CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Active Director 2015-07-15 until 2021-01-29 RESIGNED £3,042,378 cash, £3,578,170 equity
TOTAL DIAGNOSTICS LIMITED Dissolved - no longer trading Director 2015-03-24 CURRENT £1 equity
STEALTHYX THERAPEUTICS LIMITED Liquidation Director 2014-12-02 until 2017-10-31 RESIGNED £121,282 cash, £116,197 equity
THE CAMBRIDGE PARTNERSHIP LIMITED Active Director 2014-11-01 CURRENT £819,020 cash, £805,306 equity
Z FACTOR LIMITED Active Director 2014-10-21 until 2021-01-29 RESIGNED £1,195,577 cash, £1,897,448 equity
METHUSELAH HEALTH UK LIMITED Active Director 2014-09-09 CURRENT £93,121 cash, £-1,234,550 equity
FUNXIONAL THERAPEUTICS LIMITED Dissolved - no longer trading Director 2014-09-01 CURRENT
APCINTEX LIMITED Active Director 2014-06-16 until 2016-12-07 RESIGNED £11,048,377 cash, £11,679,933 equity
PURPLE PHARMACEUTICALS LIMITED Dissolved - no longer trading Director 2013-07-12 CURRENT £76,426 cash, £-246,402 equity
INHIBITAXIN LIMITED Dissolved - no longer trading Director 2013-06-25 CURRENT £2,194 cash, £-596,480 equity
XO1 LIMITED Active Director 2013-02-28 until 2015-03-18 RESIGNED
ONCOMET LIMITED Dissolved - no longer trading Director 2013-02-28 CURRENT
RXCELERATE LIMITED Active Director 2012-11-07 CURRENT £1,883,271 cash, £1,776,249 equity
TOTAL MEDICAL VENTURES I LLP Active Llp Designated Member 2009-07-23 CURRENT £48,918 cash

Companies Controlled

Company Active from Level of control
C21MED I LLP 2018-10-09 Voting rights 25 to 50 percent limited liability partnership
Right to share surplus assets 25 to 50 percent limited liability partnership
Right to appoint and remove members limited liability partnership
IMHOTEX LIMITED 2020-02-05 - 2020-03-02 Ownership of shares 75 to 100 percent
Voting rights 75 to 100 percent
Right to appoint and remove directors
THE FOUNDRY (CAMBRIDGE) LIMITED 2018-01-01 Ownership of shares 75 to 100 percent
Voting rights 75 to 100 percent
Right to appoint and remove directors
TOTAL SCIENTIFIC LIMITED 2016-04-06 - 2018-04-30 Ownership of shares 25 to 50 percent
Voting rights 25 to 50 percent
HYDROGEN THERAPEUTICS LIMITED 2019-09-19 - 2020-04-29 Ownership of shares 75 to 100 percent
Voting rights 75 to 100 percent
Right to appoint and remove directors


Related People

Name Occupation Address No of Appointments
DR ALISTAIR MICHAEL STOKES Company Executive Slough 18
DR KEVIN STUART JOHNSON Company Director Luton 7
MR FRANCESCO DE RUBERTIS Venture Capitalist Altrincham, United Kingdom 18
MR CHRISTIAN DE LA TOUR Chairman Slough, United Kingdom 12
DR KONSTANTINOS EFTHYMIOPOULOS Chief Executive Officer Cambridge 2
EILEEN JANIS ANDERSON Director Aylesbury 25
MICHELE OLLIER Venture Capitalist St Albans 1
JASON EDWIN AVERY Business Executive Cambridge 2
CALLUM CAMPBELL Director Ballsham 2
DR MOUNIA CHAOUI ROULLEAU Investment Manager Cambridge, United Kingdom 1
MR MARTIN WILLIAM EDWARDS Director Cambridge, England 2
DR DAVID JOHN GRAINGER Director Duxford, United Kingdom 8
DR DAVID GRAINGER Scientist Duxford 4
DR KARL NAEGLER Investment Manager Paris, France 1
DR ROBERT SCHROFF Pharmaceutical Consultant Washington, United States Of America 1
DR MICHELE SUSANNE HILL-PERKINS Senior Technology Transfer Manager London, England 2
RICHARD WILBECK BUSH University Official London 1
MICH??LE OLLIER Venture Capitalist 1207 Geneva, Switzerland 1
YUTI CHERNAJOVSKY Professor Of Rheumatology London, England 1

Nearby People

Name Occupation Address No of Appointments
ANDREW SANDHAM Businessman And Entrepreneur Cambridge, England 1
DR ANDREW VICTOR GRAHAM MUIR Fund Manager Cambridge, England 14
JULIAN MATTHEW SMITH Cambridge, United Kingdom 1
KENNETH THOMAS CUNNINGHAM Director Cambridge, United Kingdom 2
DR ANKER LUNDEMOSE Chief Executive Officer Cambridge 3
MR JULIAN MATTHEW SMITH Chartered Accountant Cambridge, United Kingdom 6
MS AMANDA JANE BETTISON Consultant Cambridge 3
DR CATHERINE SUSAN MINSHULL BEECH Director Cambridge 5
DR ANDREW JOHN MCGLASHAN RICHARDS Biotechnology Entrepreneur Cambridge, England 26
MR ROBERT STEVEN JOHNSON Company Director Cambridge, England 7